Cycrin and Arrhythmias - a phase IV clinical study of FDA data

Summary:

Arrhythmias is reported as a side effect among people who take Cycrin (medroxyprogesterone acetate), especially for people who are female, 50-59 old, have been taking the drug for 10+ years also take Estraderm, and have Menopause.

The phase IV clinical study analyzes which people have Arrhythmias when taking Cycrin. It is created by eHealthMe based on reports of 5,085 people who have side effects when taking Cycrin from the FDA, and is updated regularly.

What is Cycrin?

Cycrin has active ingredients of medroxyprogesterone acetate. eHealthMe is studying from 5,086 Cycrin users. Check the latest studies of Cycrin.

What is Arrhythmias?

Arrhythmias (irregular heartbeat) is found to be associated with 2,754 drugs and 4,838 conditions by eHealthMe. Check the latest studies of Arrhythmias.

On Jul, 16, 2026

5,085 people reported to have side effects when taking Cycrin.
Among them, 21 people (0.41%) have Arrhythmias.

Among these 21 people:

How long have people been on Cycrin when they have Arrhythmias? *

What is the gender of people who have Arrhythmias when taking Cycrin? *

female: 95.24 %
male: 4.76 %

What is the age of people who have Arrhythmias when taking Cycrin? *

What are other drugs people take besides Cycrin? *

What are other side effects people have besides Arrhythmias? *

Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 11 people, 52.38%
Breast Lump (localized swelling that feels different from the surrounding breast tissue): 9 people, 42.86%
Diastolic Dysfunction: 8 people, 38.10%
Breast Oedema (build-up of fluid in the breast tissue): 7 people, 33.33%
Breast Calcifications (deposits of calcium that can be seen on a mammogram of the breast): 7 people, 33.33%
Mammogram Abnormal (abnormal breast examination): 7 people, 33.33%
Cardiac Murmur (an heart sound in valve abnormality): 7 people, 33.33%
Breast Fibrosis (the thickening and scarring of connective tissue, usually as a result of injury in breast): 7 people, 33.33%
Breast Cyst: 7 people, 33.33%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 7 people, 33.33%

What are the existing conditions these people have? *

Menopause (end of monthly cycles in women): 10 people, 47.62%
Depression: 8 people, 38.10%
Diabetes: 6 people, 28.57%
Menopausal Symptoms: 4 people, 19.05%
Vaginal Bleeding: 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Osteoporosis (bones weak and more likely to break): 1 person, 4.76%
Hepatitis C: 1 person, 4.76%
Fluid Retention (an abnormal accumulation of fluid in the blood): 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Cycrin and have Arrhythmias?

- Check whether Arrhythmias is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cycrin:

Cycrin (5,086 reports)

Arrhythmias treatments and more:

Arrhythmias (177,908 reports)

Browse all side effects of Cycrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Arrhythmias:

Arrhythmias (2,754 drugs)

Browse all the conditions that are associated with Arrhythmias:

Arrhythmias (4,838 conditions)

Related publications that referenced our studies

Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on medroxyprogesterone acetate (the active ingredients of Cycrin) and Cycrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.